SEEDSUPPLY INC
SEEDSUPPLY INC. is a drug discovery support company specializing in the identification of direct binders to challenging targets, particularly GPCRs and other membrane proteins.
Our proprietary Binder Selection Technology (BST)—an advanced form of Affinity Selection Mass Spectrometry—enables native-state binding assays without target solubilization, preserving functional receptor conformations.
Leveraging a curated library of over 400,000 small molecules and access to 17,000 protein targets, SEEDSUPPLY supports hit discovery, target identification and deconvolution for compounds with unknown mechanisms of action, and the generation of high-quality binding datasets.
Our capabilities are further extended through Binder2030, an AI-ready membrane-protein binder dataset designed to accelerate structure-aware and data-driven drug discovery.
SEEDSUPPLY partners with pharmaceutical and biotechnology companies worldwide to unlock novel GPCR biology and enable first-in-class therapeutic programs.
